Cabozantinib plus docetaxel and prednisone in metastatic castration-resistant prostate cancer.
BJU Int. 2021 Apr;127(4):435-444. doi: 10.1111/bju.15227. Epub 2020 Oct 23.
BJU Int. 2021.
PMID: 32969563
Free PMC article.
Clinical Trial.